» Articles » PMID: 11897054

A Homogeneous High Throughput Nonradioactive Method for Measurement of Functional Activity of Gs-coupled Receptors in Membranes

Overview
Journal J Biomol Screen
Publisher Sage Publications
Date 2002 Mar 19
PMID 11897054
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A method is described for measuring the activity of G(s)-coupled receptors in a nonradioactive homogeneous membrane-based assay. This method has several major advantages over currently used methods for measuring functional activity of G(s)-coupled receptors. The assay is high throughput (>150,000 data points/day using a single reader). Dimethyl sulfoxide tolerance is high ( approximately 10%). Compared to complex cell-based assays, there is limited potential for nonspecific compound action. This resulted in low compound hit rates in robustness screening, where hit rates from a simulated screen were 1.0% (antagonist screen) and 0.1% (agonist screen). No continuous cell culture is required for the assay, reducing cell culture overheads and allowing the screen to run every day. Automation is simple and requires no temperature- or humidity-controlled incubation. No radioactivity is required. The method relies on measurement of cyclic AMP (cAMP) generation by fluorescence polarization assay using commercially available reagents. Membranes (1-2 microg protein per well, containing anti-cAMP antibody) are transferred to 384-well plates containing 1 microl test compound. For antagonist screens, agonist is added 15 min later. After 30 min incubation at room temperature, one further assay reagent (fluorescein-cAMP in a buffer containing detergent) is added. The signal may be read after 1 h and is stable for greater than 12 h. Typical Z' for the assay is approximately 0.5.

Citing Articles

G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons.

Ho J, Stahl E, Schmid C, Scarry S, Aube J, Bohn L Sci Signal. 2018; 11(542).

PMID: 30087177 PMC: 6373773. DOI: 10.1126/scisignal.aar4309.


Procedure for calculation of potency and efficacy for ligands acting on Gs- and Gi-coupled receptors.

Meier E, Schousboe A, Belhage B Neurochem Res. 2012; 37(12):2767-75.

PMID: 23011203 DOI: 10.1007/s11064-012-0870-6.


A high-throughput screening system for G-protein-coupled receptors using β-lactamase enzyme complementation technology.

Zhao C, Yin Q, Li S Acta Pharmacol Sin. 2010; 31(12):1618-24.

PMID: 21102483 PMC: 4002942. DOI: 10.1038/aps.2010.154.


Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.

Hill S, Williams C, May L Br J Pharmacol. 2010; 161(6):1266-75.

PMID: 21049583 PMC: 3000652. DOI: 10.1111/j.1476-5381.2010.00779.x.